Return to homepagePandemic Pact

to evaluate the effectiveness of COVID-19 vaccine for the prevention of symptomatic, reverse transcription-polymerase chain reaction (RT-PCR) confirmed SARS-CoV-2 infection among healthcare workers in Kenya

Grant number: INV-033828

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021

  • Known Financial Commitments (USD)

    $600,000

  • Funder

    Gates Foundation

  • Research Location

    United Kingdom

  • Lead Research Institution

    University of Oxford

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Health Personnel

Abstract

N/A